Waters Corporation (WAT) Investor Relations Documents

Waters Corporation (WAT) investor relations documents from the company's IR site: 3 presentations, 35 press releases; latest deck 2026-08-04. Read in-app with summaries. First-party data.

Presentation — Waters Q2 2026 earnings presentation reporting $1.645B total revenue, $3.05 adjusted EPS, and $817M from the newly acquired BD Biosciences and Diagnostic Solutions business.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-04Press releaseWaters Corporation (NYSE: WAT) Reports Second Quarter 2026 Financial Results
2026-08-04Earnings deckPresentation
2026-08-04Press releasePress Release
2026-07-29Financial supplementNon-GAAP Addendum
2026-07-27Press releaseWaters Launches Industry's Most Sensitive and Robust Clinical IVD System with Xevo TQ Absolute XR IVD Mass Spectrometer
2026-07-02Press releaseDownload PDF , Waters Corporation Schedules Second Quarter 2026 Earnings Conference Call, July 2, 2026, (opens in new wi
2026-06-24Press releaseDownload PDF , IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diag
2026-06-24Press releaseIMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitori
2026-06-09Press releaseWaters Launches Coin Cell Differential Scanning Calorimeter (DSC) to Advance Battery Safety with Integrated Thermal, Evo
2026-06-09Press release沃特世推出集热分析、逸出气体分析和电化学分析功能于一体的Coin Cell差示扫描量热仪(DSC),助力推动电池安全研究
2026-06-08Press releaseWaters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization an
2026-06-08Press release沃特世率先推出反相生物分离色谱柱,GLP-1表征速度提升高达3倍、LNP组分分析提速2倍
2026-06-03Press releaseWaters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection
2026-06-03Press releaseDownload PDF , Waters Announces FDA 510(K) Clearance Of BD BACTEC FXI Culture System, Enabling Broader Access To Bloodstream Infection Diagnostics, June 3, 2026, (Opens In New Window)
2026-06-01Press releaseWaters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics
2026-06-01Press release沃特世重磅推出Cyclic IMS P20 质谱仪,树立结构生物学与空间组学研究的新标杆
2026-06-01Press releaseDownload PDF , Waters Introduces Unrivaled Sensitivity And Speed To Benchtop HRMS With Xevo MRT P10 MS, Accelerating Multiomics Research, June 1, 2026, (Opens In New Window)
2026-05-18Press releaseDownload PDF , Waters Corporation to Present at the Jefferies Global Healthcare Conference, May 18, 2026, (opens in new
2026-05-05Press releasehttps://www.prnewswire.com/news-releases/waters-corporation-nyse-wat-reports-first-quarter-2026-financial-results-302761
2026-05-05Press releaseDownload PDF , Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results, May 5, 2026, (opens in new w
2026-05-05Financial supplementFinancial Supplement
2026-05-05Press releaseWaters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results
2026-05-05Earnings deckPresentation (Opens In New Window)
2026-04-20Press releaseDownload PDF , Waters Corporation Schedules First Quarter 2026 Earnings Conference Call, April 20, 2026, (opens in new w
2026-04-15Press releaseWaters Announces CE Mark for Next-Generation Fully Automated BD BACTEC FXI Culture System for Bloodstream Infection Diag
2026-04-14Press releaseWaters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molec
2026-04-14Press release沃特世率先推出适用于UHPLC/UPLC的宽范围MALS分析系统,助力大分子快速表征
2026-04-08Press releaseDownload PDF , Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay, April 8, 2026, (opens in new window)
2026-03-18Press releaseWaters Prices Offering of Senior Notes
2026-03-09Press releaseWaters Flagship ARES‑G3 Rheometer Sets New Benchmark for Data Quality at Breakthrough Speed
2026-03-09Press release沃特世旗舰新品ARES-G3流变仪以突破性速度树立数据质量新标杆
2026-02-23Press releaseDownload PDF , Waters Corporation to Present at the TD Cowen Health Care Conference, February 23, 2026, (opens in new wi
2026-02-17Press releaseWaters Introduces Next-Generation Microflow LC Columns with MaxPeak Premier Technology, Delivering Higher Sensitivity wi
2026-02-09Press release沃特世完成与碧迪医疗生物科学与诊断解决方案业务的合并
2026-02-09PresentationPresentation(opens in new window)
2026-02-09Press releaseDownload PDF , Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses, February 9, 2026, (
2026-02-09Press releasehttps://www.prnewswire.com/news-releases/waters-corporation-nyse-wat-reports-fourth-quarter-and-full-year-2025-financial
2026-02-09Press releaseDownload PDF , Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2025 Financial Results, February 9, 2
2026-02-09Press releaseWaters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2025 Financial Results
2026-01-27Press releaseDownload PDF , Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business, January 27

WAT overview · WAT earnings · WAT financials · WAT KPIs · WAT ownership · WAT peers · WAT filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.